Depression gene

The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human depression predisposing gene, specifically the apoptotic protease activating factor 1 (APAF1) gene, some mutant alleles of w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Shattuck, Donna, Russell, Deanna, Abkevich, Victor, Neff, Chris, Cannon-Albright, Lisa, Camp, Nicola
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Shattuck, Donna
Russell, Deanna
Abkevich, Victor
Neff, Chris
Cannon-Albright, Lisa
Camp, Nicola
description The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human depression predisposing gene, specifically the apoptotic protease activating factor 1 (APAF1) gene, some mutant alleles of which cause susceptibility to depression. More specifically, the invention relates to germline mutations in the APAF1 gene and their use in the diagnosis of predisposition to depression. The invention also relates to the prophylaxis and/or therapy of depression associated with a mutation in the APAF1 gene. The invention further relates to the screening of drugs for depression therapy. Finally, the invention relates to the screening of the APAF1 gene for mutations/alterations, which are useful for diagnosing the predisposition to depression.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07544475</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07544475</sourcerecordid><originalsourceid>FETCH-uspatents_grants_075444753</originalsourceid><addsrcrecordid>eNrjZOB3SS0oSi0uzszPU0hPzUvlYWBNS8wpTuWF0twMCm6uIc4euqXFBYklqXklxfHpRYkgysDc1MTExNzUmAglAHEIH8c</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Depression gene</title><source>USPTO Issued Patents</source><creator>Shattuck, Donna ; Russell, Deanna ; Abkevich, Victor ; Neff, Chris ; Cannon-Albright, Lisa ; Camp, Nicola</creator><creatorcontrib>Shattuck, Donna ; Russell, Deanna ; Abkevich, Victor ; Neff, Chris ; Cannon-Albright, Lisa ; Camp, Nicola ; IHC Health Services, Inc</creatorcontrib><description>The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human depression predisposing gene, specifically the apoptotic protease activating factor 1 (APAF1) gene, some mutant alleles of which cause susceptibility to depression. More specifically, the invention relates to germline mutations in the APAF1 gene and their use in the diagnosis of predisposition to depression. The invention also relates to the prophylaxis and/or therapy of depression associated with a mutation in the APAF1 gene. The invention further relates to the screening of drugs for depression therapy. Finally, the invention relates to the screening of the APAF1 gene for mutations/alterations, which are useful for diagnosing the predisposition to depression.</description><language>eng</language><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7544475$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,798,881,64015</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7544475$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Shattuck, Donna</creatorcontrib><creatorcontrib>Russell, Deanna</creatorcontrib><creatorcontrib>Abkevich, Victor</creatorcontrib><creatorcontrib>Neff, Chris</creatorcontrib><creatorcontrib>Cannon-Albright, Lisa</creatorcontrib><creatorcontrib>Camp, Nicola</creatorcontrib><creatorcontrib>IHC Health Services, Inc</creatorcontrib><title>Depression gene</title><description>The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human depression predisposing gene, specifically the apoptotic protease activating factor 1 (APAF1) gene, some mutant alleles of which cause susceptibility to depression. More specifically, the invention relates to germline mutations in the APAF1 gene and their use in the diagnosis of predisposition to depression. The invention also relates to the prophylaxis and/or therapy of depression associated with a mutation in the APAF1 gene. The invention further relates to the screening of drugs for depression therapy. Finally, the invention relates to the screening of the APAF1 gene for mutations/alterations, which are useful for diagnosing the predisposition to depression.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZOB3SS0oSi0uzszPU0hPzUvlYWBNS8wpTuWF0twMCm6uIc4euqXFBYklqXklxfHpRYkgysDc1MTExNzUmAglAHEIH8c</recordid><startdate>20090609</startdate><enddate>20090609</enddate><creator>Shattuck, Donna</creator><creator>Russell, Deanna</creator><creator>Abkevich, Victor</creator><creator>Neff, Chris</creator><creator>Cannon-Albright, Lisa</creator><creator>Camp, Nicola</creator><scope>EFH</scope></search><sort><creationdate>20090609</creationdate><title>Depression gene</title><author>Shattuck, Donna ; Russell, Deanna ; Abkevich, Victor ; Neff, Chris ; Cannon-Albright, Lisa ; Camp, Nicola</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_075444753</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2009</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Shattuck, Donna</creatorcontrib><creatorcontrib>Russell, Deanna</creatorcontrib><creatorcontrib>Abkevich, Victor</creatorcontrib><creatorcontrib>Neff, Chris</creatorcontrib><creatorcontrib>Cannon-Albright, Lisa</creatorcontrib><creatorcontrib>Camp, Nicola</creatorcontrib><creatorcontrib>IHC Health Services, Inc</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Shattuck, Donna</au><au>Russell, Deanna</au><au>Abkevich, Victor</au><au>Neff, Chris</au><au>Cannon-Albright, Lisa</au><au>Camp, Nicola</au><aucorp>IHC Health Services, Inc</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Depression gene</title><date>2009-06-09</date><risdate>2009</risdate><abstract>The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human depression predisposing gene, specifically the apoptotic protease activating factor 1 (APAF1) gene, some mutant alleles of which cause susceptibility to depression. More specifically, the invention relates to germline mutations in the APAF1 gene and their use in the diagnosis of predisposition to depression. The invention also relates to the prophylaxis and/or therapy of depression associated with a mutation in the APAF1 gene. The invention further relates to the screening of drugs for depression therapy. Finally, the invention relates to the screening of the APAF1 gene for mutations/alterations, which are useful for diagnosing the predisposition to depression.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_07544475
source USPTO Issued Patents
title Depression gene
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T22%3A29%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Shattuck,%20Donna&rft.aucorp=IHC%20Health%20Services,%20Inc&rft.date=2009-06-09&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07544475%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true